Univariate analysis identified CHEK2 mutations and mutations in the HRR pathway as related to shorter PFS in ESCC patients in the training group, and the HRR pathway alterations remained independent prognostic factors for PFS on multivariate analyses (Table 4). The gene discussed is CHEK2; the disease is esophageal squamous cell carcinoma.